- Home
- ATYR vs GRAF Comparison
ATYR vs GRAF Comparison
Compare ATYR & GRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- GRAF
- Stock Information
- Founded
- ATYR 2005
- GRAF 2021
- Country
- ATYR United States
- GRAF United States
- Employees
- ATYR N/A
- GRAF N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- GRAF
- Sector
- ATYR Health Care
- GRAF
- Exchange
- ATYR Nasdaq
- GRAF NYSE
- Market Cap
- ATYR 330.7M
- GRAF 291.2M
- IPO Year
- ATYR 2015
- GRAF 2024
- Fundamental
- Price
- ATYR $4.32
- GRAF $10.16
- Analyst Decision
- ATYR Strong Buy
- GRAF
- Analyst Count
- ATYR 6
- GRAF 0
- Target Price
- ATYR $18.60
- GRAF N/A
- AVG Volume (30 Days)
- ATYR 1.0M
- GRAF 4.8K
- Earning Date
- ATYR 03-13-2025
- GRAF 01-01-0001
- Dividend Yield
- ATYR N/A
- GRAF N/A
- EPS Growth
- ATYR N/A
- GRAF N/A
- EPS
- ATYR N/A
- GRAF 0.25
- Revenue
- ATYR $235,000.00
- GRAF N/A
- Revenue This Year
- ATYR N/A
- GRAF N/A
- Revenue Next Year
- ATYR $1,299.74
- GRAF N/A
- P/E Ratio
- ATYR N/A
- GRAF $40.96
- Revenue Growth
- ATYR N/A
- GRAF N/A
- 52 Week Low
- ATYR $1.42
- GRAF $9.03
- 52 Week High
- ATYR $4.66
- GRAF $11.02
- Technical
- Relative Strength Index (RSI)
- ATYR 63.39
- GRAF N/A
- Support Level
- ATYR $3.38
- GRAF N/A
- Resistance Level
- ATYR $3.81
- GRAF N/A
- Average True Range (ATR)
- ATYR 0.27
- GRAF 0.00
- MACD
- ATYR 0.06
- GRAF 0.00
- Stochastic Oscillator
- ATYR 74.44
- GRAF 0.00
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About GRAF GRAF GLOBAL CORP
Graf Global Corp is a blank check company.